CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma

Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level of remission within two months.

In a second study of nearly two dozen patients, everyone above a certain dose responded.

T lymphocytes and cancer cells, SEM

T lymphocyte cells (blue) attached to cancer cells.